Insulet Corporation

Insulet Corporation

PODD·NASDAQ

$146.41

+2.2%
HealthcareMedical - Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

At a Glance

Live Snapshot
Market Cap$10.14B
EPS3.5100
P/E Ratio41.71
Earnings Date08/06/2026

podd

Capital Lease Obligations

Last Annual Value

48.90M

3-Year CAGR

21%

5-Year CAGR

32%

10-Year CAGR

24%

Insulet Corporation

Insulet Corporation Competitors Analysis of Capital Lease Obligations

PODD · NASDAQ
CompanyCapital Lease Obligations
CAGR 3Y
CAGR 5Y
CAGR 10Y
48.90M
18.3%45.1%68.3% 
0.00
N/AN/AN/A
STE logo
STERIS plc
NYSE:STE
155.40M
-2.9%0.4%N/A
BIIB logo
Biogen Inc.
NASDAQ:BIIB
290.40M
-10.1%-2.5%33.3%
95.60M
-2.2%5.7%N/A
745.60M
-6.1%-4.2%26.4%
537.00M
2.2%1.7%54.3%
0.00
N/AN/AN/A
DXCM logo
DexCom, Inc.
NASDAQ:DXCM
148.80M
-2.3%-3.3%37.9%
Insulet Corporation

Insulet Corporation Fair Value Envelope

PODD · NASDAQ

Our analysis suggests that PODD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $146.41, this represents a potential HIDDEN relative to our calculated worth for Insulet Corporation.

Intrinsic Value
Current Price: $146.41